MX2011013126A - Alimentos medicos con glicomacropeptido para el manejo nutricional de fenilcetonuria y otros trastornos metabolicos. - Google Patents

Alimentos medicos con glicomacropeptido para el manejo nutricional de fenilcetonuria y otros trastornos metabolicos.

Info

Publication number
MX2011013126A
MX2011013126A MX2011013126A MX2011013126A MX2011013126A MX 2011013126 A MX2011013126 A MX 2011013126A MX 2011013126 A MX2011013126 A MX 2011013126A MX 2011013126 A MX2011013126 A MX 2011013126A MX 2011013126 A MX2011013126 A MX 2011013126A
Authority
MX
Mexico
Prior art keywords
phenylketonuria
medical foods
metabolic disorders
glycomacropeptide
nutritional management
Prior art date
Application number
MX2011013126A
Other languages
English (en)
Inventor
Denise M Ney
Mark R Etzel
Original Assignee
Wisconsin Alumni Res Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=42677045&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MX2011013126(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Wisconsin Alumni Res Found filed Critical Wisconsin Alumni Res Found
Publication of MX2011013126A publication Critical patent/MX2011013126A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/01—Hydrolysed proteins; Derivatives thereof
    • A61K38/012—Hydrolysed proteins; Derivatives thereof from animals
    • A61K38/018—Hydrolysed proteins; Derivatives thereof from animals from milk
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Nutrition Science (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Mycology (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Se describen alimentos médicos que contienen glicomacroproteína y cantidades complementarias adicionales de arginina, leucina y opcionalmente otros aminoácidos, como tirosina. Los alimentos médicos pueden ser usados para proporcionar los requerimientos completos de proteína para pacientes que tienen trastornos metabólicos como fenilcetonuria.
MX2011013126A 2009-06-12 2010-06-11 Alimentos medicos con glicomacropeptido para el manejo nutricional de fenilcetonuria y otros trastornos metabolicos. MX2011013126A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US18669009P 2009-06-12 2009-06-12
PCT/US2010/038340 WO2010144821A1 (en) 2009-06-12 2010-06-11 Glycomacropeptide medical foods for nutritional management of phenylketonuria and other metabolic disorders

Publications (1)

Publication Number Publication Date
MX2011013126A true MX2011013126A (es) 2012-02-13

Family

ID=42677045

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2011013126A MX2011013126A (es) 2009-06-12 2010-06-11 Alimentos medicos con glicomacropeptido para el manejo nutricional de fenilcetonuria y otros trastornos metabolicos.

Country Status (14)

Country Link
US (3) US8604168B2 (es)
EP (1) EP2440232B1 (es)
JP (1) JP2012530067A (es)
CN (2) CN102481338A (es)
AU (1) AU2010259975B2 (es)
BR (1) BRPI1013089A2 (es)
CA (1) CA2764571C (es)
CL (1) CL2011003120A1 (es)
DK (1) DK2440232T3 (es)
ES (1) ES2669094T3 (es)
MX (1) MX2011013126A (es)
NZ (1) NZ596902A (es)
PT (1) PT2440232T (es)
WO (1) WO2010144821A1 (es)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012004585A1 (en) * 2010-07-09 2012-01-12 Abdulla Badawy Ingestible formulation comprising glycomacropeptide and at least one of tryptophan, tyrosine and phenylalanine and uses thereof
US9180168B2 (en) * 2012-01-31 2015-11-10 Wisconsin Alumni Research Foundation Use of glycomacropeptide to improve women's health
JP2015518470A (ja) * 2012-03-26 2015-07-02 プロニュートリア・インコーポレイテッドＰｒｏｎｕｔｒｉａ， Ｉｎｃ． 栄養タンパク質および方法
RU2014143029A (ru) 2012-03-26 2016-05-20 Проньютриа, Инк. Заряженные питательные белки и способы их применения
SG11201405841RA (en) * 2012-03-26 2014-10-30 Pronutria Inc Nutritive fragments, proteins and methods
JP2015519878A (ja) 2012-03-26 2015-07-16 プロニュートリア・インコーポレイテッドＰｒｏｎｕｔｒｉａ， Ｉｎｃ． 栄養断片、タンパク質、および方法
WO2014076252A1 (en) 2012-11-15 2014-05-22 Arla Foods Amba Method of producing a composition containing caseinomacropeptide
FR3002831B1 (fr) * 2013-03-11 2015-07-17 Lactalis Nutrition Sante Produit alimentaire pret a consommer pour patients atteints d'une maladie du metabolisme d'un ou de plusieurs acides amines
WO2014171813A1 (en) * 2013-04-17 2014-10-23 N.V. Nutricia Nutritional composition for improving brain function in phenylketonuria
CN103462003A (zh) * 2013-08-13 2013-12-25 甘肃华羚生物技术研究中心 苯丙酮尿症病患者专用特膳食品
CN107223019A (zh) 2013-09-25 2017-09-29 胺细拉健康公司 用于维持和提高肌肉质量、强度和性能的组合物和制剂及其产生和使用方法
SI3071047T2 (sl) 2013-10-23 2023-04-28 Arla Foods Amba Kazeinomakropeptid vsebujoči, visokoproteinski denaturirani sirotkini proteinski sestavki, proizvodi, ki jih vsebujejo, in uporabe le-teh
CA2927685C (en) 2013-10-23 2022-03-15 Arla Foods Amba High protein, fruit flavoured beverage; high protein, fruit and vegetable preparation; and related methods and food products
EP3060065A1 (en) 2013-10-23 2016-08-31 Arla Foods amba High protein denatured whey protein composition, related products, method of production and uses thereof
CA2881076C (en) 2014-02-06 2022-06-07 Cambrooke Foods, Inc. Liquid nutritional formula for phenylketonuria patients
WO2016003263A1 (en) * 2014-07-01 2016-01-07 N.V. Nutricia Amino acid based diet with improved taste
US10124036B2 (en) 2015-06-12 2018-11-13 Cambrooke Therapeutics, Inc. Liquid nutritional formula for tyrosinemia patients
US20180144820A1 (en) * 2016-10-24 2018-05-24 Habit, Llc System and method for implementing meal selection based on vitals, genotype and phenotype
IT201800006268A1 (it) * 2018-06-13 2019-12-13 Formulazione nutrizionale per la gestione della dieta per la fenilchetonuria e metodo di realizzazione
CN113214363B (zh) * 2019-09-27 2022-12-06 湖北康肽药业有限公司 一组特殊膳食蛋白质
IT202000008203A1 (it) * 2020-04-17 2021-10-17 D M F Dietetic Metabolic Food S R L Composizione nutrizionale per il trattamento delle malattie metaboliche

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8823804D0 (en) * 1988-10-11 1988-11-16 Holgates Nutritional Foods Ltd Proteinaceous composition
US5215750A (en) * 1991-09-04 1993-06-01 Keane Ii Michael A L-glutamine and vitamin-containing compositions effective for inducing weight loss and for weight control
ATE255821T1 (de) * 1996-08-30 2003-12-15 Nestle Sa Ernährungsrezept für phenylketonurie-patienten
US5968586A (en) 1997-10-09 1999-10-19 Wisconsin Alumni Research Foundation Production of κ-casein macropeptide for nutraceutical uses
US6168823B1 (en) 1997-10-09 2001-01-02 Wisconsin Alumni Research Foundation Production of substantially pure kappa casein macropeptide
JPWO2002030418A1 (ja) * 2000-10-13 2004-02-19 中外製薬株式会社 脂質代謝改善用組成物
US20040077530A1 (en) * 2002-10-18 2004-04-22 Robert Portman Composition for reducing caloric intake
WO2005035001A1 (en) * 2003-09-29 2005-04-21 Enos Pharmaceuticals, Inc. Sustained release l-arginine formulations and methods of manufacture and use
US7744930B2 (en) * 2002-11-22 2010-06-29 Shaklee Corporation Compositions, methods and kits for enhancing weight loss while inhibiting loss of lean body mass
US7951410B2 (en) 2003-04-14 2011-05-31 Mead Johnson Nutrition Company Enteral compositions containing caseinoglycomacropeptide having an enhanced concentration of sialic acid
DK1708690T3 (en) * 2003-11-17 2016-11-07 Biomarin Pharm Inc TREATMENT OF PHENYLKETONURI WITH BH4
DE602006018856D1 (de) * 2005-01-18 2011-01-27 Dsm Ip Assets Bv Neue nutrazeutika-zusammensetzungen

Also Published As

Publication number Publication date
CN106983854A (zh) 2017-07-28
NZ596902A (en) 2013-09-27
AU2010259975A1 (en) 2011-12-22
EP2440232B1 (en) 2018-02-28
US8604168B2 (en) 2013-12-10
CA2764571C (en) 2018-12-18
EP2440232A1 (en) 2012-04-18
PT2440232T (pt) 2018-03-23
CL2011003120A1 (es) 2012-05-25
AU2010259975B2 (en) 2014-10-23
DK2440232T3 (en) 2018-04-30
BRPI1013089A2 (pt) 2016-04-05
WO2010144821A1 (en) 2010-12-16
US20130196024A1 (en) 2013-08-01
US20140248414A1 (en) 2014-09-04
CA2764571A1 (en) 2010-12-16
CN102481338A (zh) 2012-05-30
US20100317597A1 (en) 2010-12-16
US10258074B2 (en) 2019-04-16
JP2012530067A (ja) 2012-11-29
ES2669094T3 (es) 2018-05-24

Similar Documents

Publication Publication Date Title
MX2011013126A (es) Alimentos medicos con glicomacropeptido para el manejo nutricional de fenilcetonuria y otros trastornos metabolicos.
CA2818969A1 (en) Improved n-terminal capping modules for designed ankyrin repeat proteins
MX2021007268A (es) Formas solidas de acido {[5-(3-clorofenil)-3-hidroxipiridin-2-carb onil]amino}acetico, composiciones, y usos de las mismas.
NZ611606A (en) Low eructation composition and methods for treating and/or preventing cardiovascular disease in a subject with fish allergy/hypersensitivity
MY160552A (en) Low protein infant formula with increased essential amino acids
IN2014KN02830A (es)
MX2011012066A (es) Complementos orales que comprenden probioticos.
MX2009012255A (es) Probioticos en ambiente pre y/o postquirurgico.
WO2011084808A3 (en) Bifunctional polypeptide compositions and methods for treatment of metabolic and cardiovascular diseases
TN2012000512A1 (en) Compositions and methods of use for therapeutic low density lipoprotein - related protein 6 (lrp6) multivalent antibodies
PH12014502537A1 (en) Therapeutic uses of fibroblast growth factor 21 proteins
NZ596037A (en) Fgf21 mutants and uses thereof
EP2576578A4 (en) POLYMORPHES OF 2'-O-FUCOSYLLACTOSE AND MANUFACTURE THEREOF
TN2012000511A1 (en) Compositions and methods of use for therapeutic low density lipoprotein -related protein 6 (lrp6) antibodies
MX2012007806A (es) Composiciones farmaceuticas para administracion oral de peptidos de insulina.
EP3760638A3 (en) Compositions and methods utilizing lysophosphatidylcholine scaffolds
MX347734B (es) Anticuerpos anti-s100a4 y usos aplicaciones terapéuticas.
IN2012DN00908A (es)
WO2015031726A3 (en) Engineered primate l-methioninase for therapeutic purposes
MX2013011833A (es) Formula infantil para ser usada en la prevencion de enfermedades cardiovasculares.
BR112012027427A2 (pt) composições nutritivas e métodos para a mudança da nutrição parenteral para a nutrição enteral
PH12016500101A1 (en) Protease-resistant peptide ligands
MX2014011614A (es) Fragmentos y proteinas nutritivas con fenilalanina baja o nula y metodos.
MX2010006650A (es) Materiales y metodos para el tratamiento de proliferacion vascular ocular patologica.
WO2011069037A3 (en) Stabilization and storage of biological pharmaceutical compositions

Legal Events

Date Code Title Description
FG Grant or registration